Skip to main content
Joseph Kim, MD, Oncology, New Haven, CT, Yale-New Haven Hospital

JosephWoongKimMD

Oncology • New Haven, CT

Genitourinary Oncology, Hematologic Oncology

Associate Professor (Medical Oncology)

Telehealth Available

Request Appointment

Overview of Dr. Kim

Dr. Joseph Kim is an oncologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Wake Forest School of Medicine of Wake Forest Baptist Medical Center and has been in practice 10 years. He is one of 134 doctors at Yale-New Haven Hospital who specialize in Oncology. He also speaks multiple languages, including Korean. He has more than 100 publications and over 500 citings.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2007 - 2010
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2007
  • Covenant College
    Covenant CollegeB.A., 2001

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2013 - 2024
  • GA State Medical License
    GA State Medical License 2009 - 2014
  • MD State Medical License
    MD State Medical License 2011 - 2014
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
  • Merit Award American Society of Clinical Oncology, 2013
  • Young Investigator Award American Society of Clinical Oncology, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Transferable anticancer innate immunity in spontaneous regression/complete resistance mice  
    Hicks, A.M., Riedlinger, G., Willingham, M.C., Alexander-Miller, M.A., Von Kap-Herr, C., Pettenati, M.J., Sanders, A.M., Weir, H.M., Du, W., Kim, J., Simpson, A.J., Ol..., Proc Natl Acad Sci U.S.A., 1/16/2006

Books/Book Chapters

  • Bethesda Handbook of Clinical Oncology 
    Chapter: Chapter 34: Hematopoietic Growth Factors. 
    Kim, J.W., Singh, N., and Arlen, P.Editors: J. Abraham, J.L. Gulley JL, and C.J. Allegra.Lippincott Williams & WilkinsEdition 4th,2014
  • Principles of Molecular Diagnostics and Personalized Cancer Medicine 
    Chapter: Chapter 45: Vaccines and Cancer Therapy. 
    Page 594 - 609Kim, J.W., Gulley, J.L.Editors: D. Tan, and H. Lynch.Lippincott Williams & Wilkins, Philadelphia, PAEdition 1st,2013

Abstracts/Posters

  • Single-agent LV305 to induce anti-tumor immune and clinical responses in patients with advanced or metastatic sarcoma and other cancers expressing NY-ESO-1.
    Neeta Somaiah, Matthew Stephen Block, Joseph W. Kim, Geoffrey Shapiro, Khanh Tu Do, Patrick Hwu, Joseph Paul Eder, Robin Lewis Jones, Sacha Gnjatic, Hailing Lu, Jan Te..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
  • Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.
    Padmanee Sharma, Petri Bono, Joseph W. Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi Narayana Pillai, Patrick Alexander Ott, Filippo G. De Braud, Michael A. Morse, ..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
  • CheckMate-032: Phase I/II, open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (...
    Yelena Yuriy Janjigian, Johanna C. Bendell, Emiliano Calvo, Joseph W. Kim, Paolo Antonio Ascierto, Padmanee Sharma, Patrick Alexander Ott, Petri Bono, Dirk Jaeger, T.R..., J Clin Oncol; ASCO Annual Meeting, 1/1/2016
  • Join now to see all

Lectures

  • Overcoming Resistance 
    Orlando, FL - 1/1/2015
  • Overcoming Immune Suppression in Genitourinary Cancers 
    Philadelphia, PA - 1/1/2015
  • Advanced Prostate Cancer and Treatment 
    John DeQuattro Cancer Center, Manchester, CT - 1/1/2014
  • Join now to see all

Press Mentions

  • Joseph Kim, MD, on Liquid Biopsies as a Diagnostic for GI Cancers
    Joseph Kim, MD, on Liquid Biopsies as a Diagnostic for GI CancersJanuary 28th, 2020
  • Phase 3 Trial for Inovio's VGX-3100 in Cervical Dysplasia Gets FDA Go-Ahead
    Phase 3 Trial for Inovio's VGX-3100 in Cervical Dysplasia Gets FDA Go-AheadJune 14th, 2017

Grant Support

  • Young Investigator Award - 2013ASCOPresent

Professional Memberships

Other Languages

  • Korean

Hospital Affiliations

Dr. Joseph Kim, Dr. Joseph Kim, MD, Dr. J Kim, Dr. Joseph Woong Kim